101 related articles for article (PubMed ID: 25283079)
1. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.
Zhang Y; Meng Z; Zhang M; Tan J; Tian W; He X; Fu Q; Xu K; He Q; Zhu M; Li X; Zhang G; He Y; Jia Q; Zhang J; Wang S; Song X
Life Sci; 2014 Nov; 118(1):39-45. PubMed ID: 25283079
[TBL] [Abstract][Full Text] [Related]
2. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
3. Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma.
Sethi K; Sarkar S; Das S; Rajput S; Mazumder A; Roy B; Patra S; Mohanty B; El-Naggar AK; Mandal M
J Exp Ther Oncol; 2011; 9(3):187-99. PubMed ID: 22070050
[TBL] [Abstract][Full Text] [Related]
4. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer.
Meng Z; Tan J; Zhang G; Tian W; Fu Q; Li W; He X; Wu S; Yang Z; Liang X; Dong L; Zhang Q; Liu L; Zhang Y; Xu K; Liu B; Li N; Li X; Jia Q; He Y; Wang S; Wang R; Zheng W; Song X; Zhang J; Hu T; Liu N; Upadhyaya A
Life Sci; 2015 Jun; 130():18-24. PubMed ID: 25817231
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
[TBL] [Abstract][Full Text] [Related]
7. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
8. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
9. [The expression and clinical significance of SphK1 and nuclear factor-κB p65 in human colon carcinoma].
Su YJ; Huang JA; Liu SQ; Huang JX; Zhong YY; Tang GD; Jiang HX
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):220-4. PubMed ID: 22781898
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor (ER)-beta, but not ER-alpha, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma.
Ceresini G; Morganti S; Graiani V; Saccani M; Milli B; Usberti E; Valenti G; Ceda GP; Corcione L
Thyroid; 2006 Dec; 16(12):1215-20. PubMed ID: 17199431
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
[TBL] [Abstract][Full Text] [Related]
12. The levels of NF-κB p50 and NF-κB p65 play a role in thyroid carcinoma malignancy in vivo.
Le F; Zhang JY; Liu W; Huang XM; Luo WZ
J Int Med Res; 2018 Oct; 46(10):4092-4099. PubMed ID: 30014762
[TBL] [Abstract][Full Text] [Related]
13. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
14. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
16. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.
Gannon PO; Lessard L; Stevens LM; Forest V; Bégin LR; Minner S; Tennstedt P; Schlomm T; Mes-Masson AM; Saad F
Eur J Cancer; 2013 Jul; 49(10):2441-8. PubMed ID: 23541563
[TBL] [Abstract][Full Text] [Related]
17. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.
Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G
Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591
[TBL] [Abstract][Full Text] [Related]
18. Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC).
Nassar A; Gupta P; LiVolsi VA; Baloch Z
Diagn Cytopathol; 2003 Nov; 29(5):243-5. PubMed ID: 14595788
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract][Full Text] [Related]
20. [Study of the role of nuclear factor-kappa B in preterm birth with subclinical chorioamnionitis].
Yao S; Luo ZZ; Li D; Zhou CJ
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):670-4. PubMed ID: 19087517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]